PubRank

Benjamin N Bekele

Author PubWeight™ 15.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. Clin Cancer Res 2007 4.45
2 Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo. Cancer Gene Ther 2004 1.32
3 Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer. Clin Cancer Res 2004 1.26
4 Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade. Cancer Res 2004 1.26
5 An orthotopic model of anaplastic thyroid carcinoma in athymic nude mice. Clin Cancer Res 2005 1.23
6 Epidemiology and outcomes of serious influenza-related infections in the cancer population. Cancer 2005 1.17
7 mda-7 In combination with bevacizumab treatment produces a synergistic and complete inhibitory effect on lung tumor xenograft. Mol Ther 2007 1.07
8 Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer. Mol Cancer Ther 2005 1.04
9 AEE788, a dual tyrosine kinase receptor inhibitor, induces endothelial cell apoptosis in human cutaneous squamous cell carcinoma xenografts in nude mice. Clin Cancer Res 2005 0.92
10 Cost-effectiveness of influenza vaccination in working-age cancer patients. Cancer 2007 0.90
11 Thalidomide/estramustine/paclitaxel in metastatic androgen-independent prostate cancer. Clin Genitourin Cancer 2006 0.88